Incannex Healthcare (IXHL) Long-Term Investments (2025 - 2026)

Incannex Healthcare's (IXHL) quarterly Long-Term Investments came in at $27000.0 in Q1 2026, down 52.63% quarter-over-quarter from $57000.0 in Q4 2025.

Incannex Healthcare (IXHL) Long-Term Investments (2025 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Long-Term Investments across 2 years of filings, most recently posting $27000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 1.32 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.33 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 26.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.90 Mn
10 Incannex Healthcare 45.81 Mn 45.81 Mn - 27,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 27,000.00
Dec 31, 2025 57,000.00
Sep 30, 2025 45,000.00